HOME >> BIOLOGY >> NEWS
Health of coral reefs detected from orbit

coverage constraints. We need a system that has appropriate coverage and revisit frequency, with a sufficient amount of spectral bands and sensitivity. There is no more suitable system than MERIS."

The team studied Heron Island reef at the southern end of the Great Barrier Reef, site of a University of Queensland research station. Validating MERIS Full Resolution mode results, they found that observed changes in live coral cover were correlated to an existing bleaching event.

Theoretical studies indicate that for each complete 300-metre pixel of coral under one metre of water it is possible to detect a 2% bleaching of live coral. MERIS should remain sensitive to detecting from 7-8% bleached coral even under ten metres of water.

"MERIS Full Resolution covers the world every three days, a bottleneck for global monitoring could be data processing," Dekker concludes. "However satellite sensors measuring sea surface temperature such as Envisat's Advanced Along Track Scanning Radiometer (AATSR) can be applied to prioritise reefs that are subject to sea temperature heating anomalies-thus focusing the MERIS based bleaching detection.

Australia's Great Barrier Reef Marine Park Authority has expressed interest in the project. Australian scientists plan to progress to perform MERIS monitoring of bleaching events up to the scale of the whole Great Barrier Reef.


'"/>

Contact: Mariangela D'Acunto
mariangela.dacunto@esa.int
39-06-941-80-856
European Space Agency
3-Oct-2005


Page: 1 2

Related biology news :

1. Sugar and spice and everything nice: Health differences in newborn girls and boys
2. Health Physics Society
3. Johns Hopkins Bloomberg School of Public Health, Geisinger launch new environmental research group
4. Health care reimagined: Improving patient care through early health
5. Healthy coral reefs hit hard by warmer temperatures
6. Healthy reefs hit hardest by warmer temperatures
7. Kent State University and Summa Health System receive NIH grant to study prehypertension
8. Health disparities -- Genetics, society and race play an important role in access to healthcare
9. OneWorld Health selects Odyssey Research for phase 4 study in India
10. Healthy coastal wetlands would adapt to rising oceans
11. New Geisinger Health System building green Center for Health Research

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Health coral reefs detected from orbit

(Date:4/14/2015)... 14, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... focused on the growing mobile commerce market, announces that ... 2015 New York Design Awards under the category  ,Product ... City Design Awards are part of a global multi-disciplinary ... ratings from the marketplace, industry and judging panel. Winners ...
(Date:4/9/2015)... SAN JOSE, Calif. , April 9, 2015 /PRNewswire/ ... of human interface solutions, announced today that it will ... 2015 on Thursday, April 23, 2015, after the close ... call for analysts and investors at 2:00 p.m. PT ... information.    To participate on the live ...
(Date:4/2/2015)... April 2, 2015 At its 2015 ACMG ... City , the American College of Medical Genetics ... directors to its Board.  Members of the ACMG Board ... for forming and advancing its policies and programs. ACMG ... "It,s an eventful time in medical genetics ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3Synaptics to Report Third Quarter Results on April 23 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 4American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 5American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 6American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 7American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 8
(Date:4/16/2015)... (PRWEB) April 16, 2015 A new ... it easier for research institutions to learn how Appleā€™s ... data. , The timing is ideal since Apple made ... Research Kit is an open-source framework for developing medical ... provides a way for researchers to collect secure clinical ...
(Date:4/16/2015)... SAN DIEGO , April 16, 2015 ... company dedicated to improving cancer surgeries, announced today that ... lead fluorescent cancer illuminator, AVB-620, in women with primary, ... trial, the company also welcomed the addition of ... affairs. The open label, dose escalation study ...
(Date:4/16/2015)... and MENLO PARK, Calif. , April ... DMPI) (DelMar and the Company), a biopharmaceutical company focused ... orphan drug indications, today announced that the Mayo ... clinical trial site for the ongoing, multicenter Phase I/II ... (GBM), the most common and deadly form of human ...
(Date:4/16/2015)... Seattle, Washington (PRWEB) April 16, 2015 ... for Applied Cancer Science and Resolution Bioscience, Inc. ... agreement to co-develop a novel, blood-based, clinic ready, ... lung cancer (NSCLC). The collaboration is the first ... ALK, RET, and ROS1 fusions in blinded plasma ...
Breaking Biology Technology:Infographic Illustrates Potential for Research Kit to Impact Clinical Research 2Infographic Illustrates Potential for Research Kit to Impact Clinical Research 3Avelas Biosciences Initiates Phase 1b Trial of AVB-620 in Breast Cancer Patients 2Avelas Biosciences Initiates Phase 1b Trial of AVB-620 in Breast Cancer Patients 3DelMar Pharmaceuticals Adds Fourth Clinical Trial Site in Phase I/II Multicenter Study of VAL-083 for Recurrent Malignant Glioma 2DelMar Pharmaceuticals Adds Fourth Clinical Trial Site in Phase I/II Multicenter Study of VAL-083 for Recurrent Malignant Glioma 3DelMar Pharmaceuticals Adds Fourth Clinical Trial Site in Phase I/II Multicenter Study of VAL-083 for Recurrent Malignant Glioma 4DelMar Pharmaceuticals Adds Fourth Clinical Trial Site in Phase I/II Multicenter Study of VAL-083 for Recurrent Malignant Glioma 5Resolution Bioscience announces successful collaboration on a novel, non-invasive, targeted NGS test for lung cancer 2Resolution Bioscience announces successful collaboration on a novel, non-invasive, targeted NGS test for lung cancer 3
Cached News: